Effects of GLP-1 Receptor Agonist on Chronic Axonal Damage, Neurodegeneration, and Cognitive Function in Relapsing-remitting MS (MSGLP): Exploratory, Open Label, Randomized Controlled Trial

oleh: Richard Imrich, Ph.D., DSc., Adela Penesová, M.D., Ph.D., Miroslav Vlček, Žofia Rádiková, M.D., Ph.D., Andrea Havranová, M.S., Pavol Šiarnik, M.D., Ph.D., Miroslava Hardoňová, M.D., Branislav Kollár, M.D., Ph.D., Peter Turčáni, M.D., Ph.D.